AstraZeneca is in hot water with the U.K.’s drug marketing watchdog, the Prescription Medicines Code of Practice Authority (PMCPA), after it ruled that the Big Pharma made some serious errors of ...
Viatris Inc. VTRS announced that the company and partner Kindeva Drug Delivery L.P. have won a court decision that invalidates AstraZeneca's AZN patent for Symbicort. The U.S. District Court for the ...
Viatris and Kindeva Drug Delivery announced that they have won a significant court decision in which the U.S. District Court for the Northern District of West Virginia found that AstraZeneca's ...
In the courtroom fracas over the patents on AstraZeneca’s multibillion-dollar inhaler Symbicort, Viatris and Kindeva Drug Delivery have toppled yet another intellectual property pillar. Still, ...
AstraZeneca, the UK-based maker of popular inhalers like Symbicort and Airsupra, announced Monday it plans to cap costs for patients using its inhalers in the U.S. at $35 per month starting June 1.
PITTSBURGH, Nov. 10, 2022 /PRNewswire/ -- Viatris Inc (VTRS). (NASDAQ: VTRS), a global healthcare company, today announced that it and Kindeva Drug Delivery L.P. have won a significant court decision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results